Pediatric doses of frequently used hemodynamic drugs
| Drug | Dose |
|---|---|
| Dopamine | 2–28 µg/kg/min |
| Dobutamine | 2–20 µg/kg/min |
| Epinephrine | 0.02–0.2 µg/kg/min |
| Nitroprusside | 0.2–5 µg/kg/min |
| Nitroglycerin | 0.2–10 µg/kg/min |
| Prostaglandin E1 | 0.01–0.2 µg/kg/min |
| Enalapril | 0.1 mg/kg/day qd/bid |
| Captopril | 0.1–0.5 mg/kg/day q8h |
| Lisinopril | 0.07 mg/kg/day qd |
| Losartan | 0.1 mg/kg/day |
| Sildenafil | 0.5–2 mg/kg |
| Milrinone | Loading 25–100 µg/kg |
| Infusion 0.27–0.75 µg/kg/min | |
| Levosimendan | Loading 6–12 µg/kg |
| Infusion 0.05–0.1 µg/kg/min | |
| Isoproterenol | 0.01–0.2 µg/kg/min |
| Norepinephrine | 0.02–0.2 µg/kg/min |
| Phenylephrine | 0.02–0.3 µg/kg/min |
| Vasopressin | 0.01–0.05 U/kg/h |
| Esmolol | 100–700 µg/kg/min |
The most frequent causes of cyanosis and differential cyanosis and their relationship to the ductus arteriosus
| Type of cyanosis | Type of lesion | Ductal-dependent |
|---|---|---|
| Cyanosis | Hypoplastic left heart syndrome | Yes |
| Tetralogy of Fallot with pulmonary atresia | Yes | |
| Pulmonary atresia with intact interventricular septum | Yes | |
| Critical pulmonary stenosis | Yes | |
| Tricuspid atresia | Yes | |
| Severe neonatal Ebstein anomaly | Yes | |
| Transposition of the great arteries | Yes | |
| Truncus arteriosus | No | |
| Total anomalous pulmonary venous connection | No | |
| Differential cyanosis | Critical aortic stenosis | Yes |
| Critical coarctation of the aorta | Yes | |
| Interrupted aortic arch | Yes |